Mode [ftcn]
Heart failure [dsyn]
findings [ftcn]
Atlas [bpoc]
Trial [resa]
Objective [inpr]
investigate [ftcn]
Marker [clna]
Mode [ftcn]
Patients [podg]
Chronic heart failure [dsyn]
Design [acty]
DOUBLE BLIND [resa]
Parallel Study [resa]
Group [idcn]
Atlas [bpoc]
Assessment [hlca]
treatment [ftcn]
Lisinopril [aapp, phsu]
Survival [acty]
Patients [podg]
Patients [podg]
mild moderate [qlco]
Severe [qlco]
Chronic heart failure [dsyn]
New York Heart Association Class IV [fndg]
Functional [ftcn]
Ii [aapp]
interventions [hlca]
High dose [qnco]
mg% [qnco]
Low dose [qnco]
mg% [qnco]
Lisinopril [aapp, phsu]
Once daily [tmco]
months [tmco]
Main [qlco]
Outcome Measures [qnco]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
Sudden death [patf]
Chronic heart failure [dsyn]
Prognostic Factor [clna]
risk analysis [qlco]
Mode [ftcn]
Classified [clas]
Independent [idcn]
End Point [qlco]
Committee [grup]
Age [orga]
Sex [orgf]
Pre-existing [qlco]
ischaemic heart disease [dsyn]
Increasing [ftcn]
heart rate [clna]
Creatinine [bacs, orch]
Concentration [menp]
Certain [qlco]
Drugs [phsu]
Taken [cnce]
Randomization [resa]
Marker [clna]
Increased [qnco]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
Sudden death [patf]
Markers, Risk [qlco]
Chronic heart failure [dsyn]
Blood Pressure, Low [fndg]
Systolic [tmco]
baseline [bodm]
Raised [qnco]
Creatinine [bacs, orch]
Reduced [qlco]
Serum sodium [lbpr]
Haemoglobin [aapp, bacs]
Increased heart rate [fndg]
Chronic heart failure [dsyn]
Beta-Blockers [phsu]
Anti-arrhythmic Agent [phsu]
Amiodarone [orch, phsu]
Reduced [qlco]
Sudden death [patf]
Long [qlco]
ACT [topp]
Nitrates [chvs]
Previous [tmco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Marker [clna]
Increased [qnco]
Conclusions [idcn]
risk analysis [qlco]
Atlas [bpoc]
Study [mnob]
Identified [qlco]
variables [qlco]
Certain [qlco]
Mode [ftcn]
Heart failure [dsyn]
Patients [podg]
Approach [spco]
Make [ftcn]
Patients [podg]
Benefit [qnco]
Therapeutic Interventions [topp]
